For circumstances when drugmakers feel labeling alone isn’t enough to ensure safe selection and use, the FDA is proposing a rule that would expand the pool of nonprescription drugs with “self-selection systems” that would identify the appropriate patients and guide them in taking the medicines safely.
Source: Drug Industry Daily